NEW YORK (360Dx) – With at least a moderate level of certainty, harm outweighs the benefits of screening for ovarian cancer in asymptomatic women who are not at high risk, according to the US Preventive Services Task Force, a panel of experts that makes recommendations on clinical preventive services to primary care clinicians.

In a draft recommendation statement requesting public comment, the USPSTF said it has found "adequate evidence" that harm includes false-positive screening results that can lead to surgical interventions in women who do not have cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sep
20

This webinar will discuss how next-generation sequencing (NGS) can help clinical research labs and pathologists save time, money, and samples compared to single-analyte oncology research assays.

Sep
21

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.

Sep
27

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.